Efficacy of Insulin Infusion in Managing Severe Hypertriglyceridemia in PICU: A Single-Center Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202601597821166

Enrollment

Registered

2026-01-23

Start date

2024-12-31

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Nutritional, Metabolic, Endocrine Paediatrics

Interventions

Insulin Infusion for management of severe hypertriglyceridemia in pediatric patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients aged 1 month to 14 years 2) Gender : both sexes will be included 3)Admission to the PICU with severe hypertriglyceridemia (> 1000 mg/dl) or HTG-induced pancreatitis 4)Informed consent obtained

Exclusion criteria

Exclusion criteria: Patients with the following conditions: 1- Diabetic ketoacidosis 2- Obesity 3- Hypothyroidism 4- Renal and hepatic disorders.

Design outcomes

Primary

Measure	Time frame
Evaluate the efficacy of insulin infusion in the treatment of severe pediatric hypertriglyceridemia; Evaluate the prevalence of pancreatitis based on prior attacks as reported in medical history and during hospital stay	—

Secondary

Measure	Time frame
Assess the frequency of relapse and complications within one-year post-discharge ;Assess the role of pediatric intensive care units in the therapeutic regimen for treatment of severe hypertriglyceridemia.	—

Countries

Egypt

Contacts

Public ContactAhmed Gomaa

Department of pediatrics faculty of medicine Cairo university

drmada1020@gmail.com+201065044568

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026